GeneDx Holdings Corp. (WGS) Free cash flow 2019–2025
GeneDx Holdings Corp. (WGS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$14.3MFY2025 · since FY2019: -$30.7M → $14.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.3M | +142.0% |
| FY2024 | -$34.0M | +81.7% |
| FY2023 | -$185.4M | +43.2% |
| FY2022 | -$326.3M | -63.3% |
| FY2021 | -$199.8M | -70.5% |
| FY2020 | -$117.2M | -282.4% |
| FY2019 | -$30.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice